Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2010.173 | Relation Between Intra-Renal Cytokine Expression and Histological Class of Lupus Nephritis | Prof. SZETO Cheuk Chun |
| 2018.582 | Pharmacological Treatment of Mitochondrial Dysfunction in Diabetic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.601 | Optimization of Urine Processing for Biomarker Development of Kidney Diseases |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.333 | A Randomized, Multicenter, Double-Blind, Parallel-Group, Active-Control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy |
Prof SZETO Cheuk Chun 司徒卓俊 |
| 2020.643 | The Efficacy and Safety of SGLT2 Therapy in Advanced Diabetic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.224 | Optimal Strategy for the Monitoring of Dialysis Adequacy in Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2019.283 | The role of Activating Transcription Factor 5 (ATF5) for mitochondrial protection in diabetic kidney disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.245 | Defining the Optimal Duration of Treatment for “Low-Risk” Peritoneal Dialysis-Related Peritonitis |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2018.271 | A Phase 2 Study to Evaluate the Safety and Effect on Proteinuria of OMS721 in Subjects with IgA Nephropathy, Lupus Nephritis, Membranous Nephropathy, or C3 Glomerulopathy including Dense Deposit Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2019.363 | Intra-renal miR-21 expression in IgA nephropathy |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2019.646 | Regulation of Peritoneal Transport by the Cyclooxygenase Pathway and Its Pharmacological Modulation |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2008.057 | Reversal of Endotoxaemia and Vascular Dysfunction by Physiological Dialysis Solution in Diabetic Peritoneal Dialysis Patients | Dr. Szeto Cheuk-chun |
| 2009.057 | The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy | Prof. Szeto Cheuk-Chun |
| 2009.007 | The Prevalence and Prognostic Implication of Malnutrition in Chinese Peritoneal Dialysis Patients | Prof. Szeto Cheuk-Chun |
| 2009.009 | Urinary Micro-RNA Level ini Patients with Lupus Nephritis | Prof. Szeto Cheuk-Chun |
| 2012.554 | A study to compare the “Ergomotor” Intervention Program to conventional physiotherapy treatment in managing work-related neck-shoulder disorders: A randomized controlled trial | Dr SZETO Pui Yuk Grace |
| 2016.448 | To understand the attitudes of the patients receiving palliative care, their relatives and health professionals towards using Traditional Chinese Medicine treatment in Hong Kong Palliative care. |
Miss TAI Pui Hei 戴沛希 |
| 2009.327 | Drug attitude of psychiatric patients and their relatives before and after a psychoeducation talk | Dr. Tai Wing Ki |
| 2011.299 | The Capacity of Everyday Decision Making in Patients with Schizophrenia | Dr Tai Wing Ki |
| 2011.300 | Would Change in Subjective Perception of Illness Affect Duration of Acute Hospitalization in Chinese Patients with Schizophrenia? | Dr Tai Wing Ki |
| 2020.213 | Exploring the relationship between oral health and quality of life among people with schizophrenia spectrum disorder in Tai Po district community | Ms. TAI Yik Shan |
| 2009.357 | Non-Invasive Optical Biopsy in Cervical Specimens by Using Nonlinear Optical Microscopy: A Preliminary and Feasibility Study | Dr. Tak-Hong Cheung |
| 2022.649 | Intracranial nasofrontal dermoid cyst and a hair in the nose tip without a sinus tract identified |
Dr. TAM Aurora Ka Yue 譚嘉裕 |
| 2023.644 | Randomized controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for vocal cord cyst | Dr. TAM Aurora Ka Yue |
| 2021.170 | Randomised controlled trial of awake transnasal laser-assisted surgery (TNLS) and microlaryngeal surgery for benign laryngeal lesions | Dr. TAM Aurora Ka Yue |
| 2022.123 | Case report of multisystemic smooth muscle dysfunction syndrome (MSMDS) in Hong Kong | Dr Tam Catherine Wing Yan |
| 2009.632 | Walking balance of patients with ankle sprain after rehabilitations Vs normal people: A comparative study | Tam Choi Chi |
| 2023.560 | Clinical utility of lipoprotein(a) and its related polygenic risk score in risk stratification of cardiovascular complications among Chinese patients with type 2 diabetes |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2017.681 | Early growth genetics and cardiometabolic risk in Chinese adolescents |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2015.718 | Opt-out HIV testing in out-patient setting | Prof. TAM Greta Chun Huen |
| 2017.224 | Predicting excess hospital burden using temperature forecasts | Prof. TAM Greta Chun Huen |
| 2023.498 | A mhealth social support program on health behaviors among people at risk of metabolic syndrome: a feasibility randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2023.290 | Type 2 Diabetes Distress Assessment System and Acceptance and Action Diabetes Questionnaire: Validation of questionnaires in Chinese Population | Dr. TAM Hon Lon |
| 2023.010 | A resource-oriented educational program on health behaviors among people at risk of metabolic syndrome | Dr. TAM Hon Lon |
| 2024.363 | Nurse-led acceptance-based healthy lifestyles program for community-dwelling patients with pneumoconiosis: A waitlist pilot randomized controlled trial |
Dr. TAM Hon Lon 譚漢麟 |
| 2024.185 | Outcomes of Transnasal Endoscopic Repair of Spontaneous Anterior Skull Base Cerebrospinal Fluid Leak - a Hong Kong Tertiary Center Review | Dr. TAM Ka Yue Aurora |
| 2024.182 | Causal machine learning models for prediction of serious infection events in inflammatory arthritis: a population-based study |
Prof Tam Lai Shan Lai Shan TAM |
| 2024.352 | A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.221 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.193 | Lowest Efficacious Dose in Psoriatic Arthritis (LED PsA): A Multicentre Non-inferiority Randomized Open-Label Controlled Trial Assessing b/tsDMARDs Spacing | Prof. TAM Lai Shan |
| 2015.697 | Freely circulating microRNAs as biomarkers for fracture and bone loss in female patients with systemic lupus erythematosus on long-term glucocorticoid therapy |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.065 | Phase 3b/4 Randomized Safety Endpoint Study Of 2 Doses Of Tofacitinib In Comparison To A Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | Prof. TAM Lai Shan |
| 2016.359 | A double-blind, randomised, placebo-controlled trial evaluating the effect of BI 655064 administered as sub-cutaneous injections, on renal response after one year of treatment, in patients with active lupus nephritis |
Prof. TAM Lai Shan 譚麗珊教授 |
| 2017.261 | The impact of nurse-led programme with and without statin treatment base on traditional cardiovascular risk score or carotid ultrasound on addressing cardiovascular risk in patients with arthritis: a prospective, multicentre, randomised, controlled trial | Prof. TAM Lai Shan |
| 2017.389 | A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) – SELECT – PsA 1 | Prof. TAM Lai Shan |
| 2017.683 | Calprotectin in psoriatic arthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2014.343 | Adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQOL) and Psoriatic Arthritis Quality of Life (PsAQOL) questionnaires in Hong Kong | Prof. TAM Lai Shan |
| 2017.146 | Circulating microRNAs as biomarkers for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.239 | The Hong Kong Psoriatic Arthritis Screening program | Prof. TAM Lai Shan |
| 2014.387 | Coronary atherosclerosis in psoriatic arthritis | Prof. TAM Lai Shan |
Page 193 of 254.